Back to Search Start Over

Risk management of metabolic disorders in the use of antipsychotics

Authors :
G. E. Mazo
A. O. Kibitov
Source :
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 3, Pp 85-97 (2018)
Publication Year :
2018
Publisher :
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation, 2018.

Abstract

Cardio-metabolic risk factors and diabetes mellitus type 2 are highly prevalent in patients with schizophrenia. Decrease of metabolic risks associated with use of atypical antipsychotics is connected with the development of specialised programs. They can prevent and treat metabolic disorders. This article presents a comprehensive approach to the problem and proposes a solution to minimise the risk of metabolic disorders. The analysis dependence risk of formation of metabolic disorders with genetic factors, behavioral disorders, associated with schizophreniaand therapypresented in the article.

Details

Language :
Russian
ISSN :
23137053 and 2713055X
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Publication Type :
Academic Journal
Accession number :
edsdoj.5adafaebbf3416eaf79986f1c5ad2ec
Document Type :
article